Innovative Medicines Canada proposes framework for innovative agreements for drug reimbursement

16 January 2023 - Pharmaceutical manufacturers in Canada often enter into product listing agreements, particularly with public payers, to facilitate their ...

Read more →

Health charities and patient groups join together to protect access to breakthrough medical treatments in Canada

19 October 2020 - Patients shut out of process leading to the release of revised guidelines by the Patented Medicine Prices ...

Read more →

Direct or indirect comparison: reliance on innovative drug data key to engaging data protection

15 August 2020 - The Federal Court recently issued its decision in Natco v Canada (Minister of Health), 2020 FC 788, ...

Read more →

Is innovation causing accessibility, timing issues for private drug plans?

17 January 2020 - Pharmaceutical companies and private payers can interact in different ways to ensure the right drugs are ...

Read more →

Pharmacare with no new medicines

10 December 2019 - Meeting with pricing officials shows that government's true goal is to slash prices so low that no ...

Read more →

New drug landscape dominated by high cost medicines

19 February 2019 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, ...

Read more →

Quebec appeals court orders province to restore full coverage of rheumatoid-arthritis drug Remicade

13 February 2019 - Quebec’s highest court has ordered the provincial government to restore full public coverage of Remicade, an ...

Read more →

Ottawa’s push for lower drug costs may hurt patients, stunt innovation

24 January 2019 - The federal government’s plan to lower prescription drug prices could impede access and thus limit the ...

Read more →

Innovative drugs need a new regulatory approach

10 April 2018 - Innovative drugs help people enjoy longer, healthier, more productive lives. They also allow our health-care systems ...

Read more →

Brand name drug sales soar in Canada, while R&D sags

1 December 2017 - Patented drug industry disputes it's failing to invest enough into research and development. ...

Read more →